Sedia Biosciences is a privately held medical device and diagnostics company based in Beaverton, Oregon. Their mission is to advance global access to healthcare by developing innovative disease surveillance and monitoring tools, expanding accessible point-of-care diagnostic testing, and providing cost-effective specimen collection devices.
With a focus on infectious diseases, Sedia Biosciences develops rapid and cost-effective assays that provide results from various specimens, including blood, serum, plasma, and oral fluid. They also specialize in developing enzyme immunoassays to distinguish recent HIV infections from long-term ones, enabling aggressive treatment and customized therapy. Additionally, Sedia offers genomic analysis solutions for human, plant, and animal systems, combining next-generation DNA sequencing with fractional sequencing technologies.
Generated from the website